Results 61 to 70 of about 15,396 (182)

Pneumococcal conjugate vaccine use in adults

Expert Review of Vaccines, 2015
Streptococcus pneumoniae is a leading cause of illness and death in adults. A polysaccharide vaccine has been available for over 30 years, but despite significant use, the public health impact of this vaccine has been limited. The 13-valent pneumococcal conjugate vaccine (PCV13) has been licensed by the US Food and Drug Administration and other ...
Raul E. Isturiz, Beate Schmoele-Thoma, Daniel A. Scott, Luis Jodar, Chris Webber, Heather L. Sings, Peter Paradiso   +6 more
openaire   +2 more sources

Effectiveness of Pneumococcal Polysaccharide Vaccine for Preschool-Age Children with Chronic Disease

Emerging Infectious Diseases, 1999
To estimate the effectiveness of pneumococcal polysaccharide vaccine, we serotyped isolates submitted to the Pneumococcal Sentinel Surveillance System from 1984 to 1996 from 48 vaccinated and 125 unvaccinated children 2 to 5 years of age.
Anthony E. Fiore, Orin S. Levine, John A. Elliott, Richard R. Facklam, Jay C. Butler   +4 more
doaj   +1 more source

Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children

Journal of Immunology Research, 2015
Applications of the heptavalent pneumococcal conjugate vaccine (PCV7) in the pediatric immunization schedule have dramatically reduced the incidence of pneumococcal diseases in both vaccinated children and unvaccinated individuals of all ages.
Susanna Esposito, Nicola Principi
doaj   +1 more source

Overall effectiveness of pneumococcal conjugate vaccines: An economic analysis of PHiD-CV and PCV-13 in the immunization of infants in Italy

Human Vaccines & Immunotherapeutics, 2017
Pneumococcal diseases are associated with a significant clinical and economic burden. The 7-valent pneumococcal conjugate vaccine (PCV-7) has been used for the immunization of newborns against invasive pneumococcal diseases (IPD) in Italy while now, the ...
Paolo Castiglia, Lorenzo Pradelli, Stefano Castagna, Veronica Freguglia, Giorgio Palù, Susanna Esposito   +5 more
doaj   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Approaches to vaccination of adults against pneumococcal disease in different countries of the world

Журнал инфектологии
Various pneumococcal vaccines are available worldwide, differing in the range of serotypes coverage and type of vaccine, which determine different mechanisms of action and postvaccinal immunity. Vaccination  against  pneumococcal infection is recommended
A. S. Korovkin, Yu. I. Obukhov, E. N. Syatchikhina   +2 more
doaj   +1 more source

Streptococcus pneumoniae serotypes/serogroups causing invasive disease in Riyadh, Saudi Arabia : Extent of coverage by pneumococcal vaccines

Annals of Saudi Medicine, 2005
BACKGROUND : Serogroup distribution of sterile site pneumococcal isolates varies between developing and developed countries as well as between different geographical regions.
Al-Mazrou Abdulrahman, Twum-Danso Kingsley, Al Zamil Fahad, Kambal Abdelmageed   +3 more
doaj  

Effect of pneumococcal conjugate vaccine six years post-introduction on pneumococcal carriage in Ulaanbaatar, Mongolia

Nature Communications
Limited data from Asia are available on long-term effects of pneumococcal conjugate vaccine introduction on pneumococcal carriage. Here we assess the impact of 13-valent pneumococcal conjugate vaccine (PCV13) introduction on nasopharyngeal pneumococcal ...
Claire von Mollendorf, Tuya Mungun, Munkhchuluun Ulziibayar, Paige Skoko, Laura Boelsen, Cattram Nguyen, Purevsuren Batsaikhan, Bujinlkham Suuri, Dashtseren Luvsantseren, Dorj Narangerel, Bilegtsaikhan Tsolmon, Sodbayar Demberelsuren, Belinda D. Ortika, Casey L. Pell, Ashleigh Wee-Hee, Monica L. Nation, Jason Hinds, Eileen M. Dunne, E. Kim Mulholland, Catherine Satzke   +19 more
doaj   +1 more source

Triptych of the Hermit Saints: pneumococcal polysaccharide vaccines for the elderly

Risk Management and Healthcare Policy, 2018
Ger T Rijkers,1,2 Laura IE Yousif,1 Simone MC Spoorenberg,3 Frans J van Overveld1 1Department of Science, University College Roosevelt, Middelburg, the Netherlands; 2Department of Medical Microbiology and Immunology, St. Antonius Hospital ...
Rijkers GT, Yousif LIE, Spoorenberg SMC, van Overveld FJ   +3 more
doaj